These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8126011

  • 1. Hylan gel biomaterial: dermal and immunologic compatibility.
    Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazs EA.
    J Biomed Mater Res; 1993 Sep; 27(9):1129-34. PubMed ID: 8126011
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of hylan g-f 20 in Guinea pigs and mice.
    Sasaki M, Miyazaki T, Nakamura T, Takahashi T, Miyauchi S, Iwata H.
    J Rheumatol; 2004 May; 31(5):943-50. PubMed ID: 15124255
    [Abstract] [Full Text] [Related]

  • 3. Hylan G-F 20 induces delayed foreign body inflammation in Guinea pigs and rabbits.
    Sasaki M, Miyazaki Y, Takahashi T.
    Toxicol Pathol; 2003 May; 31(3):321-5. PubMed ID: 12746120
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of in vivo biocompatibility and biodegradation of photocrosslinked hyaluronate hydrogels (HADgels).
    Miyamoto K, Sasaki M, Minamisawa Y, Kurahashi Y, Kano H, Ishikawa S.
    J Biomed Mater Res A; 2004 Sep 15; 70(4):550-9. PubMed ID: 15307159
    [Abstract] [Full Text] [Related]

  • 5. Antigenicity study of muroctasin.
    Yamaguchi F, Hattori H, Wagai N, Tsukada W.
    Arzneimittelforschung; 1988 Jul 15; 38(7A):1034-7. PubMed ID: 3190797
    [Abstract] [Full Text] [Related]

  • 6. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis.
    Ishikawa M, Yoshioka K, Urano K, Tanaka Y, Hatanaka T, Nii A.
    Osteoarthritis Cartilage; 2014 Nov 15; 22(11):1902-9. PubMed ID: 25153804
    [Abstract] [Full Text] [Related]

  • 7. Hylan gel composition for percutaneous embolization.
    Larsen NE, Leshchiner EA, Parent EG, Hendrikson-Aho J, Balazs EA, Hilal SK.
    J Biomed Mater Res; 1991 Jun 15; 25(6):699-710. PubMed ID: 1874755
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model.
    Ottaviani RA, Wooley P, Song Z, Markel DC.
    J Bone Joint Surg Am; 2007 Jan 15; 89(1):148-57. PubMed ID: 17200322
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of hylan b gel as a soft-tissue augmentation implant material.
    Piacquadio D, Jarcho M, Goltz R.
    J Am Acad Dermatol; 1997 Apr 15; 36(4):544-9. PubMed ID: 9092739
    [Abstract] [Full Text] [Related]

  • 10. Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function.
    Hertegård S, Hallén L, Laurent C, Lindström E, Olofsson K, Testad P, Dahlqvist A.
    Laryngoscope; 2002 Dec 15; 112(12):2211-9. PubMed ID: 12461343
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, Züllig M, Guetg R, Häuselmann HJ, Schwarz H, Theiler R, Ziswiler HR, Dieppe PA, Villiger PM, Egger M, Swiss Viscosupplementation Trial Group.
    Arthritis Rheum; 2007 Nov 15; 56(11):3610-9. PubMed ID: 17968921
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration.
    Renier D, Bellato P, Bellini D, Pavesio A, Pressato D, Borrione A.
    Biomaterials; 2005 Sep 15; 26(26):5368-74. PubMed ID: 15814135
    [Abstract] [Full Text] [Related]

  • 13. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
    Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA.
    Biopolymers; 2001 Oct 05; 59(4):191-204. PubMed ID: 11473346
    [Abstract] [Full Text] [Related]

  • 14. Cross-linked hyaluronan (Hylan B gel): a new injectable remedy for treatment of vocal fold insufficiency--an animal study.
    Hallén L, Johansson C, Laurent C.
    Acta Otolaryngol; 1999 Jan 05; 119(1):107-11. PubMed ID: 10219396
    [Abstract] [Full Text] [Related]

  • 15. Synovial fluid findings in a patient after hylan GF 20 injection.
    Kwan-Morley J, Clayburne G, Schumacher HR.
    J Clin Rheumatol; 2008 Apr 05; 14(2):120. PubMed ID: 18391685
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves.
    Ramamurthi A, Vesely I.
    Biomaterials; 2005 Mar 05; 26(9):999-1010. PubMed ID: 15369688
    [Abstract] [Full Text] [Related]

  • 17. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial.
    Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP.
    J Hand Surg Am; 2008 Jan 05; 33(1):40-8. PubMed ID: 18261664
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of rabbit anti-ovalbumin antibodies sensitizing human, guinea pig and rabbit skin.
    Richerson HB, Cheng HF, Seebohm PM.
    J Immunol; 1968 Dec 05; 101(6):1291-9. PubMed ID: 5749194
    [No Abstract] [Full Text] [Related]

  • 19. The role of Na-hylan in reducing postsurgical tendon adhesions.
    Weiss C, Levy HJ, Denlinger J, Suros JM, Weiss HE.
    Bull Hosp Jt Dis Orthop Inst; 1986 Dec 05; 46(1):9-15. PubMed ID: 3015301
    [Abstract] [Full Text] [Related]

  • 20. Viscoelastic properties of rabbit vocal folds after augmentation.
    Hertegård S, Dahlqvist A, Laurent C, Borzacchiello A, Ambrosio L.
    Otolaryngol Head Neck Surg; 2003 Mar 05; 128(3):401-6. PubMed ID: 12646844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.